Styliani Mantziari

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 31

Top Topics

Locally Advanced

Positron Emission Tomography

Neoadjuvant Chemotherapy

Top Venues

Annals of surgical oncology

Revue medicale suisse

This page only lists publications with an associated author ORCID identifier.

Publications

Styliani Mantziari, Hugo Teixeira Farinha, Guillaume Piessen, Markus Schäfer
ASO Author Reflections: Neoadjuvant Radiotherapy in Locally Advanced Esophageal Adenocarcinoma; Low-Dose Radiation, Low-Dose Expectations? Annals of surgical oncology (2024)
Francesco Abboretti, Céline Lambert, Markus Schäfer, Bruno Pereira, Bertrand Le Roy, Diane Mège, Guillaume Piessen, Johan Gagnière, Caroline Gronnier, Styliani Mantziari, null null, null null
Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients: A Multicenter Propensity Score Analysis. Annals of surgical oncology 31 (8) (2024)
Styliani Mantziari, Hugo Teixeira Farinha, Guillaume Piessen, Markus Schäfer
ASO Author Reflections: Neoadjuvant Radiotherapy in Locally Advanced Esophageal Adenocarcinoma; Low-Dose Radiation, Low-Dose Expectations? Annals of surgical oncology (2024)
Styliani Mantziari, Jessie A Elliott, Sheraz R Markar, Fredrik Klevebro, Lucas Goense, Asif Johar, Pernilla Lagergren, Giovanni Zaninotto, Richard van Hillegersberg, Mark Ivo van Berge Henegouwen, Markus Schäfer, Magnus Nilsson, George B Hanna, John V Reynolds, null null
Sex-related differences in oncologic outcomes, operative complications and health-related quality of life after curative-intent oesophageal cancer treatment: multicentre retrospective analysis. BJS open 8 (2) (2024)
Francesco Abboretti, Céline Lambert, Markus Schäfer, Bruno Pereira, Bertrand Le Roy, Diane Mège, Guillaume Piessen, Johan Gagnière, Caroline Gronnier, Styliani Mantziari, null null, null null
Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients: A Multicenter Propensity Score Analysis. Annals of surgical oncology 31 (8) (2024)
Styliani Mantziari, Hugo Teixeira Farinha, Guillaume Piessen, Markus Schäfer
ASO Author Reflections: Neoadjuvant Radiotherapy in Locally Advanced Esophageal Adenocarcinoma; Low-Dose Radiation, Low-Dose Expectations? Annals of surgical oncology 31 (4) (2024)
Styliani Mantziari, Hugo Teixeira Farinha, Marguerite Messier, Michael Winiker, Pierre Allemann, Esat Mahmut Ozsahin, Nicolas Demartines, Guillaume Piessen, Markus Schäfer
ASO Visual Abstract: Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal Cancer Patients. Annals of surgical oncology (2024)
Styliani Mantziari, Jessie A Elliott, Sheraz R Markar, Fredrik Klevebro, Lucas Goense, Asif Johar, Pernilla Lagergren, Giovanni Zaninotto, Richard van Hillegersberg, Mark Ivo van Berge Henegouwen, Markus Schäfer, Magnus Nilsson, George B Hanna, John V Reynolds, null null
Sex-related differences in oncologic outcomes, operative complications and health-related quality of life after curative-intent oesophageal cancer treatment: multicentre retrospective analysis. BJS open 8 (2) (2024)
Francesco Abboretti, Céline Lambert, Markus Schäfer, Bruno Pereira, Bertrand Le Roy, Diane Mège, Guillaume Piessen, Johan Gagnière, Caroline Gronnier, Styliani Mantziari, null null, null null
Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients: A Multicenter Propensity Score Analysis. Annals of surgical oncology (2024)
Styliani Mantziari, Hugo Teixeira Farinha, Guillaume Piessen, Markus Schäfer
ASO Author Reflections: Neoadjuvant Radiotherapy in Locally Advanced Esophageal Adenocarcinoma; Low-Dose Radiation, Low-Dose Expectations? Annals of surgical oncology 31 (4) (2024)
Francesco Abboretti, Markus Schäfer, Caroline Gronnier, Styliani Mantziari
ASO Author Reflections: Neoadjuvant Chemotherapy in cT2N0M0 Gastric Cancer; Time to Revisit Current Recommendations? Annals of surgical oncology (2024)
Francesco Abboretti, Céline Lambert, Markus Schäfer, Bruno Pereira, Bertrand Le Roy, Diane Mège, Guillaume Piessen, Johan Gagnière, Caroline Gronnier, Styliani Mantziari, null null, null null
ASO Visual Abstract: Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients-A Multicenter Propensity Score Analysis. Annals of surgical oncology (2024)
Francesco Abboretti, Markus Schäfer, Caroline Gronnier, Styliani Mantziari
ASO Author Reflections: Neoadjuvant Chemotherapy in cT2N0M0 Gastric Cancer; Time to Revisit Current Recommendations? Annals of surgical oncology (2024)
Francesco Abboretti, Markus Schäfer, Caroline Gronnier, Styliani Mantziari
ASO Author Reflections: Neoadjuvant Chemotherapy in cT2N0M0 Gastric Cancer; Time to Revisit Current Recommendations? Annals of surgical oncology 31 (9) (2024)
Francesco Abboretti, Markus Schäfer, Caroline Gronnier, Styliani Mantziari
ASO Author Reflections: Neoadjuvant Chemotherapy in cT2N0M0 Gastric Cancer; Time to Revisit Current Recommendations? Annals of surgical oncology 31 (9) (2024)
Francesco Abboretti, Céline Lambert, Markus Schäfer, Bruno Pereira, Bertrand Le Roy, Diane Mège, Guillaume Piessen, Johan Gagnière, Caroline Gronnier, Styliani Mantziari, null null, null null
Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients: A Multicenter Propensity Score Analysis. Annals of surgical oncology 31 (8) (2024)
Sergio Gaspar Figueiredo, Pierre Allemann, Alexander Berend-Jan Borgstein, Gaëtan-Romain Joliat, Valentine Luzuy-Guarnero, Christophe Brunel, Christine Sempoux, Suzanne Sarah Gisbertz, Nicolas Demartines, Mark Ivo van Berge Henegouwen, Markus Schäfer, Styliani Mantziari
Impact of positive microscopic resection margins (R1) after gastrectomy in diffuse-type gastric cancer. Journal of cancer research and clinical oncology (2023)
Lucie Favre, Johanna Frantz, Styliani Mantziari
[Interdisciplinary Center for Obesity: a single-entry point for personalized care]. Revue medicale suisse 19 (819) (2023)
Styliani Mantziari, Penelope St Amour, Francesco Abboretti, Hugo Teixeira Farinha, Sergio Gaspar Figueiredo, Caroline Gronnier, Dimitrios Schizas, Nicolas Demartines, Markus Schäfer
A Comprehensive Review of Prognostic Factors in Patients with Gastric Adenocarcinoma. Cancers 15 (5) (2023)
Styliani Mantziari, Penelope St Amour, Francesco Abboretti, Hugo Teixeira Farinha, Sergio Gaspar Figueiredo, Caroline Gronnier, Dimitrios Schizas, Nicolas Demartines, Markus Schäfer
A Comprehensive Review of Prognostic Factors in Patients with Gastric Adenocarcinoma. Cancers 15 (5) (2023)
Johanna Frantz, Styliani Mantziari, Lucie Favre
[Stigmatization of people with obesity: understanding and confronting societal prejudice]. Revue medicale suisse 19 (819) (2023)
Hugo Teixeira Farinha, Damien Bouriez, Thomas Grimaud, Ana-Maria Rotariu, Denis Collet, Styliani Mantziari, Caroline Gronnier
Gastro-Intestinal Disorders and Micronutrient Deficiencies following Oncologic Esophagectomy and Gastrectomy. Cancers 15 (14) (2023)
Eric Zandirad, Hugo Teixeira Farinha, Beatriz Barberá-Carbonell, Sandrine Geinoz, Nicolas Demartines, Markus Schäfer, Styliani Mantziari
Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option? Cancers 14 (23) (2022)
Hugo Teixeira Farinha, Antonia Digklia, Dimitrios Schizas, Nicolas Demartines, Markus Schäfer, Styliani Mantziari
Immunotherapy for Esophageal Cancer: State-of-the Art in 2021. Cancers 14 (3) (2022)
Eric Zandirad, Hugo Teixeira Farinha, Beatriz Barberá-Carbonell, Sandrine Geinoz, Nicolas Demartines, Markus Schäfer, Styliani Mantziari
Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option? Cancers 14 (23) (2022)
Styliani Mantziari, Theodoros Thomopoulos, Francesco Abboretti, Sergio Gaspar-Figueiredo, Anna Dayer, Nicolas Demartines, Michel Suter
Long-term weight loss and metabolic benefit from Roux-en-Y gastric bypass in patients with superobesity. BJS open 6 (6) (2022)
Eric Zandirad, Hugo Teixeira Farinha, Beatriz Barberá-Carbonell, Sandrine Geinoz, Nicolas Demartines, Markus Schäfer, Styliani Mantziari
Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option? Cancers 14 (23) (2022)
Styliani Mantziari, Hugo Teixeira Farinha, Vianney Bouygues, Jean-Charles Vignal, Yannick Deswysen, Nicolas Demartines, Markus Schäfer, Guillaume Piessen
Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis. Cancers 13 (9) (2021)
Styliani Mantziari, Anastasia Pomoni, John O Prior, Michael Winiker, Pierre Allemann, Nicolas Demartines, Markus Schäfer
18F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer. BMC medical imaging 20 (1) (2020)
Ismail Labgaa, Styliani Mantziari, Maxime Genety, Jessie A Elliott, Satoshi Kamiya, Marianne C Kalff, Michaël Winiker, Jérôme Pasquier, Pierre Allemann, Marguerite Messier, Mark I van Berge Henegouwen, Magnus Nilsson, John V Reynolds, Guillaume Piessen, Martin Hübner, Nicolas Demartines, Markus Schäfer
Early postoperative decrease of albumin is an independent predictor of major complications after oncological esophagectomy: A multicenter study. Journal of surgical oncology 123 (2) (2020)
Styliani Mantziari, Pierre Allemann, Michael Winiker, Christine Sempoux, Nicolas Demartines, Markus Schäfer
Sterilization of tumor-positive lymph nodes of esophageal cancer by neo-adjuvant treatment is associated with worse survival compared to tumor-negative lymph nodes treated with surgery first. Journal of surgical oncology 116 (4) (2017)